For patients with metachronous isolated oligometastatic cancer of gynecologic origin to the supraclavicular fossa, do you prefer standard fractionation therapy to cover the entire supraclav or SBRT to the involved nodes?
1 Answers
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network
Have preferred treating the entire region with sib boost to node.
